Tag Archives: ACMPR

BlissCo Cannabis

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

Supreme Makes Strategic Investment in Distribution Partner and Secures Supply Agreement with BlissCo

TORONTO, Ontario, Feb. 26, 2018 /Weed Wire/ — The Supreme Cannabis Company, Inc. (“Supreme Cannabis” or the “Company”) (TSXV:FIRE), is pleased to announce that it has completed a $3,000,000 strategic equity investment (the “Investment”) in BlissCo Cannabis Corp. (“BlissCo”).

SAQ

Tilray® Signs Letter of Intent with Société des alcools du Québec (SAQ) to Supply Province with Cannabis

NANAIMO AND MONTREAL, Feb. 14, 2018 /Weed Wire/ – Tilray, a global pioneer in cannabis cultivation, processing and distribution, announced today that it has signed a Letter of Intent (LOI) with Société des alcools du Québec (SAQ) to supply the province of Quebec with high-quality cannabis products in anticipation of adult-use legalization later this year.

Physical Security

Statement from Health Canada: Physical Security Requirements for Producers of Cannabis for Medical Purposes

OTTAWA, Ontario, Jan. 25, 2018 /Weed Wire/ – Health Canada is introducing two targeted changes to the physical security requirements under the Access to Cannabis for Medical Purposes Regulations (ACMPR) that must be respected by licensed producers (LP) of cannabis for medical purposes.

Transition Sundial Growers Cannabis Canada Association

Cannabis Canada Association Announces Leadership Transition

OTTAWA, Ont., Jan. 4, 2018 /Weed Wire/ — The Board of Directors of Cannabis Canada Association (“Cannabis Canada”) today announced the departure of Colette Rivet from her position of Executive Director and the appointment of Allan Rewak as Acting Executive Director, while a comprehensive search for a permanent replacement is conducted.

Sunniva David Negus

Sunniva Strengthens Management Team Prior to Public Listing

VANCOUVER, British Columbia, Jan. 3, 2018 /Weed Wire/ – Sunniva Inc. (“Sunniva” or “the Company”), a provider of medical cannabis products and services focused within the largest cannabis markets – Canada and California – is pleased to announce the appointment of Mr. David Negus, CPA, CA, as the Company’s Chief Financial Officer (“CFO”).

Return the Love

True Leaf Exercises Option to Purchase 40-acre Site in Lumby, B.C. to Build Cannabis Production Facility

VERNON, British Columbia, Jan. 2, 2017 /Weed Wire/ — True Leaf Medicine International Ltd. (“True Leaf”) (CSE: MJ) (FSE: TLA) (OTCQB: TRLFF), has exercised its option to purchase 40 acres of land that encompasses its facility in Lumby, British Columbia, Canada, through its wholly owned subsidiary True Leaf Medicine Inc.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fouth Facility

VICTORIA, British Columbia, Nov. 28, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) (“Emerald”) announced today that its licensed producer application (submitted through its subsidiary, Emerald Health Botanicals) for its new Richmond, BC greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (“OMC”).

Transition Sundial Growers Cannabis Canada Association

Statement on the Government of Québec’s plan for the Regulation of Cannabis

OTTAWA, Ontario, Nov. 21, 2017 /Weed Wire/ — Cannabis Canada, and the licensed producers of medical cannabis that it represents, share Province’s commitment to ensuring adult Quebecers have access to safe, regulated cannabis products and support the Government’s decision to make clear its intentions regarding the distribution and retail of adult-use cannabis.

GrowPros

Tetra Bio-Pharma Inc.: Rx Princeps(TM) Now Available for Patients through Licenced Producer Partner Aphria

OTTAWA, Ontario Nov. 16, 2017 /Weed Wire/ – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that Rx Princeps(TM), unique blend of dried medical cannabis used in its PPP001 clinical trials, is now available through licensed producer Aphria Inc. (“Aphria”) under Access to Cannabis for Medical Purposes Regulations (ACMPR).

Emerald Health Northern Vine Labs

Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility

RICHMOND, British Columbia, Nov. 15, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (TSXV: EMH; OTCQX: EMHTF) announced today that its licensed producer application for the Pure Sunfarms Delta 3 greenhouse facility under Access to Cannabis for Medical Purpose Regulations (“ACMPR”) has met the requirements of the paper-based review of Health Canada’s Office of Medical Cannabis (”OMC”).

Transition Sundial Growers Cannabis Canada Association

Statement on the Government of Canada’s Approach to Cannabis Taxation

OTTAWA, Ontario, Nov. 14, 2017 /Weed Wire/ — Cannabis Canada, and the licensed producers of medical cannabis it represents, share the Government of Canada’s commitment to regulating and restricting access to cannabis to keep it out of the hands of youth, and the profits out of the hands of criminals.

BlissCo Cannabis

Supreme Commences Production in New Flowering Rooms

TORONTO, Ontario, Nov. 7, 2017 /Weed Wire/ — Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (TSXV: FIRE) is pleased to announce 7ACRES has commenced production in the newly constructed flowering rooms recently approved by Health Canada.

Emerald Health Northern Vine Labs

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

VICTORIA, British Columbia, Oct. 26, 2017 /Weed Wire/ – Emerald Health Therapeutics Inc. (“Emerald”) (EMH.V) (EMHTF) announced today that it has signed a definitive agreement (the “Agreement”) with Northern Vine Canada Inc. (“Northern Vine”) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT) (ATTBF) to invest $2.5 million into Northern Vine to acquire 53% of the company and appoint three of its four directors. Abattis will continue to hold the remaining 47% of Northern Vine.

Emerald Health Northern Vine Labs

Emerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018

VICTORIA, British Columbia, Oct. 19, 2017 /Weed Wire/ — Emerald Health Therapeutics Inc. (“EHT”) (TSXV: EMH; OTCQX: EMHTF), through Emerald Health Botanicals Inc. (“Emerald”), its wholly owned subsidiary and a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), has submitted license applications to Health Canada for approval of two new growing sites.

GrowPros

Tetra Bio-Pharma Signs Agreement with Partner Aphria to Start Promoting Rx Princeps(TM), its Medical Cannabis Blend, under ACMPR

OTTAWA, Ontario, Oct. 18, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, today announced that it will start promoting a co-developed medical cannabis blend product under Access to Cannabis for Medical Purposes Regulations (ACMPR).

The Green Organic Dutchman

The Green Organic Dutchman Secures Second Property, 75 Acres Located in Quebec

HAMILTON, Ontario, Sept. 8, 2017 /Weed Wire/ – The Green Organic Dutchman Holdings Ltd. (the “Company”) is pleased to announce that it has secured a 75-acre property located in Salaberry-de-Valleyfield, Quebec (the “Quebec Property”).

Physical Security

Statement from Health Canada on Improving the Licensing of Production of Cannabis for Medical Purposes

OTTAWA, Ontario, May 26, 2017 /Weed Wire/ — Health Canada is introducing several improvements to its medical cannabis program that aim to streamline the application process for issuing production licenses and enable increased production under the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Physical Security

Statement from Health Canada on Mandatory Testing of Medical Cannabis for Unauthorized Pesticides

OTTAWA, Ontario, May 5, 2017 /Weed Wire/ – Today, Health Canada is announcing that it will require all licensed producers to conduct mandatory testing of all cannabis products destined for sale for the presence of unauthorized pesticides.

abattis bioceuticals_added_to_marijuana_index

Abattis Bioceuticals Gets Added to the Marijuana Index by MJIC

VANCOUVER, British Columbia, April 7, 2017 /Weed Wire/ — Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”), is pleased to announce it has officially been added to The Marijuana Index, within the Biotechnology sector.

THC BioMed

THC Announces $10,000,000 Capital Commitment

VANCOUVER, British Columbia, March 16, 2017 /Weed Wire/ — THC BioMed Intl Ltd. (“THC” or the “Company”) (CSE:THC) announces that it has entered into a capital commitment agreement (the “Capital Commitment”) with GEM Global Yield Fund LLC SCS (“GEM”) for a $10 million Capital Commitment from GEM to invest into THC.

Physical Security

Statement from Health Canada on the Testing of Cannabis for Medical Purposes for Unauthorized Pest Control Products

OTTAWA, Ontario, Feb. 7, 2017 /Weed Wire/ — Recently, two licensed producers of cannabis for medical purposes undertook voluntary recalls of cannabis products that contained low levels of prohibited pest control products (myclobutanil/bifenazate/pyrethrins).

Canada's First Authorized Licensee of 2017 Starts Cultivating

Canada’s First Authorized Licensee of 2017 Starts Cultivating

On Jan. 10, 2017, Health Canada authorized James E. Wagner Cultivation in Ontario to start cultivating medical cannabis, making it the 38th licensed producer in Canada and the first producer of 2017 licensed under the Access to Cannabis for Medical Purposes Regulations.

Aurora Cannabis operational update

Aurora Receives Health Canada License to Sell Cannabis Oils

VANCOUVER, British Columbia, Jan. 23, 2017 /Weed Wire/ — Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils.

Aphria

Aphria’s Vision to be Reality – Part IV Expansion Project to Increase Greenhouse Growing Space to 1 Million Square Feet

LEAMINGTON, Ontario, Jan. 16, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion.

puff ventures

PUF Ventures Provides Health Canada Update

VANCOUVER, British Columbia, Nov. 29, 2016 /Weed Wire/ — PUF Ventures Inc. (the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) is pleased to announce that further to its news release of October 18, 2016, the Company has received notice from Health Canada that it has upgraded from position 17 to position 14 in respect of its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) application for AAA Heidelberg.

Aphria

Aphria to Triple Its Production Space as it Starts Part III Expansion

LEAMINGTON, Ontario, Sept.16,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce that its Board of Directors approved a fully funded $24.5 million capital project as the first phase of its Part III expansion.

OrganiGram Inventory

OrganiGram Enters Exclusive Partnership for Oils, Extracts and Edibles

MONCTON, New Brunswick, Sept. 1, 2016 /Weed Wire/ — OrganiGram Holdings Inc. (TSX VENTURE:OGI)(OTCQB:OGRMF) (the “Company” or “OrganiGram”) is pleased to announce it has entered into an exclusive product development and distribution agreement with TGS International, LLC (“TGS International”).

Health Canada Granting Patients Right to Grow Medical Cannabis at Home

Health Canada Granting Patients Right to Grow Medical Cannabis at Home

On Aug. 11, 2016, Health Canada announced that it had replaced the Marihuana for Medical Purposes Regulations with the Access to Cannabis for Medical Purposes Regulations, as prompted by the Federal Court of Canada’s decision in Allard v. Canada.


Top